$NNVC news NanoViricides enters agreement with the University of Pittsburgh for the testing of its nanoviricides drug candidates in standard animal models of ocular virus infections (NNVC) : These animal studies will evaluate the efficacy and potency of the Company's nanoviricides anti-viral agents in ocular viral infections. The goal of these studies is to help select clinical drug development candidates for treatment of ocular herpes keratitis in humans.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.